167 related articles for article (PubMed ID: 23427138)
21. Defining multivariate normative rules for healthy aging using neuroimaging and machine learning: an application to Alzheimer's disease.
Andrade de Oliveira A; Carthery-Goulart MT; Oliveira Júnior PP; Carrettiero DC; Sato JR
J Alzheimers Dis; 2015; 43(1):201-12. PubMed ID: 25079801
[TBL] [Abstract][Full Text] [Related]
22. CSF and brain structural imaging markers of the Alzheimer's pathological cascade.
Yang X; Tan MZ; Qiu A
PLoS One; 2012; 7(12):e47406. PubMed ID: 23284610
[TBL] [Abstract][Full Text] [Related]
23. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
Hohman TJ; Bell SP; Jefferson AL;
JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
[TBL] [Abstract][Full Text] [Related]
24. Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients.
Mathieu-Kia AM; Fan LQ; Kreek MJ; Simon EJ; Hiller JM
Brain Res; 2001 Mar; 893(1-2):121-34. PubMed ID: 11223000
[TBL] [Abstract][Full Text] [Related]
25. The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk.
Zhang H; Kranzler HR; Yang BZ; Luo X; Gelernter J
Mol Psychiatry; 2008 May; 13(5):531-43. PubMed ID: 17622222
[TBL] [Abstract][Full Text] [Related]
26. Candidate genes for anorexia nervosa in the 1p33-36 linkage region: serotonin 1D and delta opioid receptor loci exhibit significant association to anorexia nervosa.
Bergen AW; van den Bree MB; Yeager M; Welch R; Ganjei JK; Haque K; Bacanu S; Berrettini WH; Grice DE; Goldman D; Bulik CM; Klump K; Fichter M; Halmi K; Kaplan A; Strober M; Treasure J; Woodside B; Kaye WH
Mol Psychiatry; 2003 Apr; 8(4):397-406. PubMed ID: 12740597
[TBL] [Abstract][Full Text] [Related]
27. Genetic susceptibility to heroin addiction: a candidate gene association study.
Levran O; Londono D; O'Hara K; Nielsen DA; Peles E; Rotrosen J; Casadonte P; Linzy S; Randesi M; Ott J; Adelson M; Kreek MJ
Genes Brain Behav; 2008 Oct; 7(7):720-9. PubMed ID: 18518925
[TBL] [Abstract][Full Text] [Related]
28. Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging.
Nelson PT; Katsumata Y; Nho K; Artiushin SC; Jicha GA; Wang WX; Abner EL; Saykin AJ; Kukull WA; ; Fardo DW
Acta Neuropathol; 2016 Dec; 132(6):841-858. PubMed ID: 27815632
[TBL] [Abstract][Full Text] [Related]
29. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
30. Genetic polymorphisms in the opioid receptor delta 1 (OPRD1) gene are associated with methadone dose in methadone maintenance treatment for heroin dependence.
Fang CP; Wang SC; Tsou HH; Chung RH; Hsu YT; Liu SC; Kuo HW; Liu TH; Chen ACH; Liu YL
J Hum Genet; 2020 Apr; 65(4):381-386. PubMed ID: 31907389
[TBL] [Abstract][Full Text] [Related]
31. Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study.
van Maurik IS; Vos SJ; Bos I; Bouwman FH; Teunissen CE; Scheltens P; Barkhof F; Frolich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Frisoni GB; Spiru L; Freund-Levi Y; Wallin AK; Hampel H; Soininen H; Tsolaki M; Verhey F; Kłoszewska I; Mecocci P; Vellas B; Lovestone S; Galluzzi S; Herukka SK; Santana I; Baldeiras I; de Mendonça A; Silva D; Chetelat G; Egret S; Palmqvist S; Hansson O; Visser PJ; Berkhof J; van der Flier WM;
Lancet Neurol; 2019 Nov; 18(11):1034-1044. PubMed ID: 31526625
[TBL] [Abstract][Full Text] [Related]
32. Association Study of Opioid Receptor Delta-Type 1 (OPRD1) Gene Variants with Nicotine Dependence in an Iranian Population.
Sharafshah A; Soltani B; Keshavarz P
J Mol Neurosci; 2021 Jun; 71(6):1301-1305. PubMed ID: 33506435
[TBL] [Abstract][Full Text] [Related]
33. A delta-opioid receptor genetic variant is associated with abstinence prior to and during cocaine dependence treatment.
Crist RC; Doyle GA; Kampman KM; Berrettini WH
Drug Alcohol Depend; 2016 Sep; 166():268-71. PubMed ID: 27449273
[TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
[TBL] [Abstract][Full Text] [Related]
35. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
[TBL] [Abstract][Full Text] [Related]
36. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.
Li X; Li TQ; Andreasen N; Wiberg MK; Westman E; Wahlund LO
J Intern Med; 2014 Apr; 275(4):418-27. PubMed ID: 24237038
[TBL] [Abstract][Full Text] [Related]
37. Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol.
Ashenhurst JR; Bujarski S; Ray LA
Pharmacol Biochem Behav; 2012 Dec; 103(2):253-9. PubMed ID: 22954510
[TBL] [Abstract][Full Text] [Related]
38. Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data.
Tosun D; Schuff N; Shaw LM; Trojanowski JQ; Weiner MW;
J Alzheimers Dis; 2011; 26 Suppl 3(0 3):77-90. PubMed ID: 21971452
[TBL] [Abstract][Full Text] [Related]
39. OPRD1 SNPs associated with opioid addiction are cis-eQTLs for the phosphatase and actin regulator 4 gene, PHACTR4, a mediator of cytoskeletal dynamics.
Levran O; Randesi M; Adelson M; Kreek MJ
Transl Psychiatry; 2021 May; 11(1):316. PubMed ID: 34031368
[TBL] [Abstract][Full Text] [Related]
40. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
